DocSym
β
Searchsearch
Search
(Y55.0) Oxytocic drugs
More details coming soon
20 955 in individuals diagnosis oxytocic drugs confirmed
4 592 deaths with diagnosis oxytocic drugs
22% mortality rate associated with the disease oxytocic drugs
Diagnosis oxytocic drugs is diagnosed Women are 45.26% more likely than Men
5 735
Men receive the diagnosis oxytocic drugs
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
15 220
Women receive the diagnosis oxytocic drugs
4 592 (30.2 %)Died from this diagnosis.
Risk Group for the Disease oxytocic drugs - Men aged 0-5 and Women aged 30-34
In Men diagnosis is most often set at age 0-5, 15-19, 35-39, 55-59
Less common in men the disease occurs at Age 0-1, 5-14, 20-34, 40-54, 60-95+Less common in women the disease occurs at Age 0-1, 10-14, 20-29, 35-44, 50-54, 60-64, 70-74, 90-95+
In Women diagnosis is most often set at age 0-9, 15-19, 30-34, 45-49, 55-59, 65-69, 75-89
Disease Features oxytocic drugs
Absence or low individual and public risk
Oxytocic drugs - what does this mean
Oxytocic drugs are medications that stimulate the uterus to contract and help to induce or speed up labor. they work by stimulating the release of oxytocin, a hormone that is naturally produced by the body during labor and delivery and causes the uterus to contract.
What happens during the disease - oxytocic drugs
Oxytocic drugs are medications that stimulate uterine contractions, which can be used to induce labor or to help strengthen labor contractions. the primary mechanism of action of oxytocic drugs is to increase the production of the hormone oxytocin, which stimulates the smooth muscle of the uterus to contract. this contraction of the uterus can help to expel the fetus from the uterus and facilitate delivery.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the patient
- Laboratory tests to check for any abnormalities in the patient's blood or urine
- Ultrasound to assess the size and position of the uterus
- Fetal monitoring to assess the baby's heart rate
- CT scan to assess the size and shape of the uterus
- Magnetic resonance imaging (MRI) to assess the size and shape of the uterus
- Uterine biopsy to assess the tissue samples
- Administration of oxytocic drugs to induce labor
- Monitoring of the patient's vital signs during labor
Treatment and Medical Assistance
Main Goal: To reduce the risk of uterine atony and postpartum hemorrhage
- Administer oxytocic drugs, such as oxytocin, ergometrine or misoprostol, as soon as possible after delivery.
- Monitor the patient's vital signs and uterine contractions closely.
- Monitor the amount of blood lost during delivery.
- Administer additional doses of oxytocic drugs as needed.
- Administer additional uterotonics if necessary.
- Administer blood transfusions if necessary.
- Monitor the patient for signs and symptoms of postpartum hemorrhage.
- Monitor the patient's hemoglobin and hematocrit levels.
- Provide supportive care and education to the patient and family.
7 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Oxytocic drugs - Prevention
Oxytocic drugs should be used with caution and only under the guidance of a medical professional. they should only be used if necessary and in accordance with a doctor's instructions. good prenatal care and regular check-ups are important to ensure the health of both mother and baby. additionally, proper nutrition and avoiding smoking, alcohol and recreational drugs can help reduce the risk of complications.